|Dr. Jifan Hu
Director, Cancer and Stem Cell Epigenetics Program, Palo Alto Veterans Affairs Institute for Research, United States.
|Jifan Hu is Tang ErQin Professor in Stem Cell and Cancer Center of the Norman Bethune First Hospital at Jilin University, and the Director of Cancer and Stem Cell Epigenetics Program, Palo Alto Veterans Affairs Institute for Research in United States. He received his Ph.D. from Cornell University, M.S. from Beijing University, and M.D. from Anhui Medical University. He took the postdoctoral training at Stanford University Medical School. As the PI, he has been in charge of research grants from NIH, US Department of Defense (DoD), California Institute for Regenerative Medicine (CIRM), National Natural Science Foundation of China (NFSC), and National Basic Research Program of China. His current research is focused on stem cell reprograming and self-renewal, noncoding RNAs, and mechanisms underlying genomic imprinting and gene regulation in cancers. He has published a series of papers in peer-reviewed journals, including Cell Stem Cell, Biomaterials, J Cell Biol, Nucleic Acids Res, Oncotarget, Oncogene, Hepatology, and Science. In a project funded by CIRM, his group demonstrates that intrachromosomal looping in pluripotency gene promoters is a critical epigenetic barrier in iPS cell reprogramming.|
|cell reprogramming, gene regulation by noncoding RNAs, and mechanisms of genomic imprinting in cancer|
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2017 All rights reserved. iMedPub Last revised : August 16, 2017